EPISODE · Mar 16, 2020 · 7 MIN
Risdiplam Under FDA Review & How the Lack of SMA Protein May Also Directly Contribute to SMA
from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today
Anticipation is growing as Roche/Genentech's treatment risdiplam, the first oral medication to treat SMA, is under FDA review.SMA News Today’s multimedia associate, Price Wooldridge, discusses how the lack of SMA protein may also directly contribute to SMA. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/
Embed this episode
Ready to play
Risdiplam Under FDA Review & How the Lack of SMA Protein May Also Directly Contribute to SMA
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.